December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Nirmala Bhoo Pathy: Join us at the 12th Asia-Pacific Breast Cancer Summit
Jan 16, 2024, 05:56

Nirmala Bhoo Pathy: Join us at the 12th Asia-Pacific Breast Cancer Summit

Nirmala Bhoo Pathy shared 12th Asia-Pacific Breast Cancer Summit 2024’s post on LinkedIn, adding:

“Come join us at the 12th Asia-Pacific Breast Cancer Summit!

I’m speaking on Women, Power, and Cancer.”

Quoting 12th Asia-Pacific Breast Cancer Summit 2024’s post:

“We are pleased to welcome Dr. Nirmala Bhoo Pathy, Professor and Consultant at Universiti of Malaya, Malaysia, as one of our esteemed Faculty at APBCS2024 happening in Bali, Indonesia!

Don’t miss her talk on ‘Women, Power and Cancer: A Lancet Commission’, and see you all on March 2-3, 2024! Register today!”

Link for the registration.
Source: Nirmala Bhoo Pathy/LinkedIn and 12th Asia-Pacific Breast Cancer Summit 2024/LinkedIn

Nirmala Bhoo-Pathy is a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician at Universiti Malaya Medical Centre, Malaysia. She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014.

Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy. Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN).

She currently serves in two Lancet Commissions: the Lancet Commission on Women and Cancer and the Lancet Commission on Cancer and Health Systems. As the founder and scientific lead of a solution-oriented research group ‘Well with Cancer in Malaysia (WeCan@MY) https://spm.um.edu.my/wecan@my/ in the Department of Social and Preventive Medicine, Nirmala Bhoo-Pathy currently oversees a wide range of studies on cancer care, cancer control and cancer policy, locally and globally.